Company Filing History:
1 out of 4 
1 out of 10 Years Active: 2012
Title: Marilene Demasi: Innovator in Anti-Inflammatory Peptides
Introduction
Marilene Demasi is a notable inventor based in São Paulo, Brazil. She has made significant contributions to the field of pharmaceuticals, particularly in the development of synthetic peptides with therapeutic applications.
Latest Patents
Marilene holds a patent for "Anti-inflammatory and anti-allergic cyclic peptides." This invention refers to synthetic, cyclic peptides containing a sequence of 13 L-amino acids in their primary structure. These peptides exhibit anti-inflammatory and anti-allergic activities, making them useful for treating acute or chronic inflammation and allergies. The invention is particularly beneficial for the treatment of acute or chronic allergic asthma. Additionally, it describes a pharmaceutical composition containing these peptides, their use, and a method to treat or prevent acute and/or chronic inflammatory and/or allergic disorders. Marilene has 1 patent to her name.
Career Highlights
Throughout her career, Marilene has worked with prominent companies, including Cristalia Produtos Quimicos Farmaceuticos Ltda. and Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP). Her work in these organizations has contributed to advancements in pharmaceutical research and development.
Collaborations
Marilene has collaborated with several professionals in her field, including Mônica Ferreira and Carla Silva. These partnerships have enhanced her research and innovation efforts.
Conclusion
Marilene Demasi's work in developing anti-inflammatory and anti-allergic peptides showcases her dedication to improving healthcare through innovative solutions. Her contributions to the pharmaceutical industry are commendable and highlight the importance of research in addressing health challenges.